Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.3.0.814
Consolidated Balance Sheets - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 140,877 $ 442,257
Inventory 198,972 392,750
Prepaid expenses, deposits and deferred costs 1,086,987 74,623
Current assets, Total 1,426,836 909,630
Property, plant and equipment, net 3,793,114 4,042,359
Assets, Total 5,219,950 4,951,989
Current liabilities:    
Accounts payable 1,781,632 1,603,555
Accounts payable, related parties 318,980 384,776
Notes payable 780,000 $ 1,243,000
Shareholder advances 1,112,200
Current portion of long-term debt 2,762,500 $ 35,904
Current liabilities, Total 6,755,312 3,267,235
Long-term debt $ 10,000 $ 2,494,141
Stockholders' equity (deficit):    
Series A preferred stock, par value of $.001 per share 75,000,000 shares authorized, 0 shares issued and outstanding at December 31, 2013 and December 31, 2012
Common stock, par value of $.001 per share 500,000,000 shares authorized, 175,998,198 shares issued and outstanding at September 30, 2015 and 149,944,982 shares issued and outstanding at December 31, 2014 $ 175,990 $ 149,937
Additional paid-in capital 31,836,256 27,128,582
Stock based compensation 6,207,284 6,002,586
Accumulated deficit during the development stage (39,764,892) (34,090,492)
Stockholders' equity (deficit), Total (1,545,362) (809,387)
Liabilities and Stockholders' Equity (Deficit), Total $ 5,219,950 $ 4,951,989